Complete remission of extensive cutaneous metastatic melanoma on the scalp under topical mono-immunotherapy with diphenylcyclopropenone

European Journal of Dermatology

Volumn 23, Issue 4, 2013, Pages 532-533

  Hinz, Torsten ^a   Ehler, Allergy Lin Kristin ^a   Bieber, Thomas ^a   Schmid Wendtner, Monika H ^b  

^a UNIVERSITY OF BONN   (Germany)

^b Interdisciplinary Oncology Center (IOZ)   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DIPHENCYPRONE; IMIQUIMOD;

AGED; CANCER IMMUNOTHERAPY; CASE REPORT; CONTACT DERMATITIS; CRYOTHERAPY; CUTANEOUS MELANOMA; DERMATITIS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; HISTOPATHOLOGY; HUMAN; IRRITANT DERMATITIS; LETTER; MALE; METASTATIC MELANOMA; SCALP; SENTINEL LYMPH NODE BIOPSY; SKIN METASTASIS; TUMOR REGRESSION;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CYCLOPROPANES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MELANOMA; SCALP; SKIN NEOPLASMS;

EID: 84884384661     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.2066     Document Type: Letter

References (10)

1. Terheyden P, Kortuem AK, Schulze HJ, et al. Chemoimmunother-apy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Derma-tologic Co-operative Oncology Group. J Cancer Res Clin Oncol 2007;133:437-444.
2. Wolf IH, Smolle J, Binder B, Cerroni L, Richtig E, Kerl H. Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol 2003;139: 273-6.
3. Arbiser JL, Bips M, Seidler A, Bonner MY, Kovach C. Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases. J Am Acad Dermatol 2012; 67: 81-3.
4. Kis E, Olah J, Ocsai H, et al. Electrochemotherapy of cutaneous metastases of melanoma - a case series study and systemic review of the evidence. Dermatol Surg 2011; 37: 816-824.
5. Trefzer U, Sterry W. Topical immunotherapy with diphenylcyclo-propenone in combination with DTIC and radiation for cutaneous metastases of melanoma. Dermatology 2005; 211: 370-1.
6. Damian DL, Shannon KF, Saw RP, Thompson JF. Topical diphen-cyprone immunotherapy for cutaneous metastatic melanoma. Australas J Dermatol 2009; 50: 266-271.
7. Strobbe LJ, Nieweg OE, Kroon BB. Carbon dioxide laser for cutaneous metastases: indications and limitations. Eur J Surg Oncol 1997;23:435-8.
8. Wack C, Kirst A, Becker JC, Lutz WK, Bröcker EB, Fischer WH. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. Cancer Immunol Immunother 2002; 51: 431-9.
9. Trcka J, Kaempgen E, Becker JC, Schwaaf A, Bröcker EB. Immunochemotherapy of metastatic malignant melanoma with epifocal DNCB and systemic DTIC. Hautarzt 1998; 49: 17-22.
10. Happle R. Therapeutic immune reactions. Hautarzt 1985; 36 (suppl. 7): 76-8.